Gain Therapeutics GANX
NASDAQ GANX
$1.29 +0.10 (+8.40%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Long-Term Investments (2022 - 2023)

Updated

Gain Therapeutics (GANX) recorded Long-Term Investments of $988,388 in Q1 2023, down 49.1% from the prior quarter.

Analysis

Gain Therapeutics (GANX) Long-Term Investments (2022 - 2023) Analysis & Trends

At the end of FY2022, Gain Therapeutics reported Long-Term Investments of $1.94 million.

  • Per Business Quant, the preceding three quarters came in at $1.94 million (Q4 2022), $2.92 million (Q3 2022) and $4.92 million (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 266.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 297.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.56 Bn
10 Gain Therapeutics 54.89 Mn -4.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 988,388.00
Dec 31, 2022 1.94 Mn
Sep 30, 2022 2.92 Mn
Jun 30, 2022 4.92 Mn
API Access

Gain Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=GANX&period=max&api_key=YOUR_API_KEY